Delivery Order V797D70252-36C26024F0466
Award Date
7/1/24
Potential Completion Date
7/8/24
Potential Value
$48K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Gilead Sciences Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VEKLURY REMDESIVIR 437, an emergency pharmaceutical supply, to the Veterans Integrated Service Network 23 (VISN 23) of the U.S. Department of Veterans Affairs (VA). The $89,916.75 firm fixed-price delivery order was awarded to Gilead Sciences Inc., a large biopharmaceutical company, under the GSA Schedule 61-IB for Pharmaceuticals and Drugs. This contract does not have a set-aside designation. Gilead holds a $29.16 million Blanket Purchase...
This federal contract award is a Delivery Order made by the Veterans Integrated Service Network (VISN) 20 of the U.S. Department of Veterans Affairs (VA) to Gilead Sciences Inc. (doing business as Gilead), a large biopharmaceutical company. The contract is for the supply of SUNLENCA 300MG TAB,PKT,5, a pharmaceutical product, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has a Firm Fixed Price pricing type and a ceiling value of $3,882.02. The contract...
This federal contract award is for the delivery of SUNLENCA 300MG TAB,PKT,4 to the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network (VISN) 20. The prime contractor is Gilead Sciences Inc., doing business as Gilead, a prominent biopharmaceutical company. The contract has a ceiling value of $3,105.62 and is a firm fixed-price delivery order under Gilead's GSA Schedule 61-IB contract for Pharmaceuticals and Drugs. This contract does not have a small...
This is a delivery order contract awarded by the Department of Veterans Affairs to Gilead Sciences Inc. to provide Veklury (remdesivir) for COVID-19 treatment. The contract has a firm fixed price of $155,700.00 and a completion date of January 31, 2021. Gilead is a biopharmaceutical company that provides pharmaceuticals and biologics to government customers through its GSA Schedule contract. Gilead has received numerous federal contracts from the VA to supply antiviral and oncology...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded Gilead Sciences Inc. a $136,237.50 firm-fixed-price delivery order contract for Veklury (remdesivir), a COVID-19 treatment. This order was placed against Gilead's existing Multiple Award Schedule (MAS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Gilead, a biopharmaceutical company, is the prime contractor and will directly provide the medication, with performance taking place in Foster City, California....
This is a Delivery Order awarded by the Veterans Integrated Service Network (VISN) 16 of the U.S. Department of Veterans Affairs (VA) to Gilead Sciences Inc. (doing business as Gilead), a prominent biopharmaceutical company. The contract is for the procurement of Veklury (remdesivir), a COVID-19 treatment medication. The contract has a firm fixed price of $77,850.00 and an ultimate completion date of July 18, 2021. The award is not associated with any set-aside designations. Gilead is the...
This federal contract award is a delivery order under Gilead Sciences Inc.'s General Services Administration (GSA) Schedule 61-IB contract for Pharmaceuticals and Drugs. The $81,742.50 firm fixed-price contract was awarded by the U.S. Department of Veterans Affairs (VA) for Veklury (remdesivir), an antiviral medication used to treat COVID-19. The contract has an ultimate completion date of September 30, 2021 and was not set aside for small businesses. Gilead Sciences, the prime contractor, is...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The order is for Veklury (remdesivir) to treat COVID-19, with a potential value of $194,625.00. As a Firm Fixed Price contract, Gilead will deliver the pharmaceutical product directly to VA medical facilities in Carrollton, TX. The award is not associated with a set-aside...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc. for the supply of INV-REMDESIVIR 100MG (COVID-19) with a potential value of $175,162.50. The contract was awarded under Gilead's General Services Administration (GSA) Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. Gilead will deliver the COVID-19 treatment medication directly to VA medical facilities. As a small business set-aside...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc., a biopharmaceutical company, for the supply of the COVID-19 antiviral medication Veklury (remdesivir). The order has a firm-fixed price of $155,700.00 and a completion date of October 29, 2021. The contract was awarded on December 9, 2020 and is placed under Gilead's existing General Services Administration (GSA) Multiple Award Schedule contract for...